Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Stefano Percio

9PUBLICATIONS

54CO-AUTHORS

Predictive and prognostic markersEpidemiological modellingMolecular targetsMedical molecular engineering of nucleic acids and proteinsVirology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 27, 2025

CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS).

Dario Callegaro, Gabriele Tinè, Felix Boakye Oppong

|Sep 16, 2024

GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.

Silvia Stacchiotti, Silvia Martini, Sandro Pasquali

|May 09, 2023

Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft.

Valentina Zuco, Sandro Pasquali, Monica Tortoreto

|Jun 10, 2022

Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma.

Irene Alessandrini, Stefano Percio, Eisa Naghshineh

|Jun 02, 2021

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer.

Silvia Martini, Valentina Zuco, Monica Tortoreto

|Jun 10, 2020

SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair.

Rihan El Bezawy, Martina Tripari, Stefano Percio

Pageof 2

Frequent Collaborators

7 joint publications

Nadia Zaffaroni

5 joint publications

Alessandro Gronchi

4 joint publications

Valentina Doldi

3 joint publications

Sandro Pasquali

3 joint publications

Paola Collini

3 joint publications

Valentina Zuco

3 joint publications

Silvia Brich

3 joint publications

Anna Maria Frezza

3 joint publications

Paolo Gandellini

2 joint publications

Marco Folini

Frequent Collaborators

7 joint publications

Nadia Zaffaroni

5 joint publications

Alessandro Gronchi

4 joint publications

Valentina Doldi

3 joint publications

Sandro Pasquali

Top Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos

Top Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos